Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2013

View Archived Issues

Combinatorial strategies to enhance antitumor efficacy of monoclonal antibodies

Functional polymorphism associated with a predisposition towards allergic asthma reported

Serum miRNAs as markers of early gastric cancer risk

Bayer begins new collaboration with Seattle Genetics

RegeneRx reports results from phase II RGN-137 trial in epidermolysis bullosa

Myriad Genetics to conduct BRCA testing for Tesaro's niraparib studies

Boston College patents new PDE11A inhibitors

CytRx reaches target enrollment in phase IIb aldoxorubicin trial

Discovery of ROR-gamma inverse agonists for the treatment of Th17-mediated autoimmune diseases

Prima BioMed to begin three phase II trials of CVac

Cytokinetics and Astellas form skeletal muscle activator collaboration

Nanobiotix to develop NBTX-IV together with the NCI

Preliminary results from phase II trial of DN24-02 in urothelial cancer

Mesoblast receives approval for trial of mesenchymal precursor cells

NICE recommends dapagliflozin in certain patients with type 2 diabetes

Zealand Pharma presents ZP-GA-1, a new glucagon analogue

Findings link FOXJ1 gene with Barrett's esophagus

Celgene presents new protein kinase inhibitors

Boehringer Ingelheim designs novel mGlu5 receptor modulators

Chiesi Farmaceutici divulges novel MAPK 14 inhibitors

QRxPharma provides update on MoxDuo NDA review

Verastem begins phase I trial of VS-4718 in advanced cancer

Phase I study of MORAb-066 commences

Vivus obtains European approval for avanafil

FDA grants fast track designation to Genervon's GM-604 in ALS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...